SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-10 23:15
Tx date 2024-03-04
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+2,222 vol
10,801
Filed 2023-12-14 21:24
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-56,883 vol
7,110
Filed 2023-12-14 21:23
Tx date 2023-03-19
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-12,776 vol
77,224
Filed 2023-12-14 21:20
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-26,667 vol
8,579
Filed 2023-12-14 21:19
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-19,264 vol
35,246
Filed 2023-12-14 21:18
Tx date 2023-11-10
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-22,714 vol
54,510
Filed 2022-06-23 13:00
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
Filed 2022-06-09 22:42
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
Filed 2022-06-09 22:42
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
120,000
Filed 2022-06-08 18:24
Tx date 2022-06-06
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$48,000
+30,000 vol
$1.60 each
90,000
Filed 2022-06-08 17:57
Tx date 2021-09-24
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-686,291 vol
63,993
Filed 2021-10-06 10:52
Tx date 2021-09-24
$XRTX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-686,376 vol
Filed 2021-12-21 21:46
Tx date 2021-12-21
$XRX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$55,044
+21,671 vol
$2.54 each
60,000
Filed 2021-10-06 10:55
Tx date 2021-09-24
$XRX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-274,447 vol
38,329
Filed 2021-10-06 10:53
Tx date 2021-09-24
$XRX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-137,224 vol
312,776
Filed 2021-10-06 10:52
Tx date 2021-09-24
$XRX
XORTX Therapeutics Inc.
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-686,376 vol
63,908
Filed 2021-03-01 10:04
Tx date 2021-02-26
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$89,285
+357,142 vol
$0.25 each
750,284
Filed 2021-03-01 10:03
Tx date 2021-02-26
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-357,142 vol
0
Filed 2020-06-27 22:31
Tx date 2020-06-23
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$42,000
+300,000 vol
$0.14 each
450,000
Filed 2020-06-27 22:31
Tx date 2018-01-25
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
150,000
Filed 2020-03-10 21:38
Tx date 2020-02-28
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+357,142 vol
357,142
Filed 2020-03-10 21:38
Tx date 2018-01-25
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-10 21:37
Tx date 2020-02-28
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$49,999
+357,142 vol
$0.14 each
393,142
Filed 2020-03-03 17:47
Tx date 2020-02-27
$MMED
Mind Medicine (MindMed) Inc. (formerly Broadway Gold Mining Ltd.)
Van Damme, Paul Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options incentive stock options
50 - Grant of options
$33,000
+100,000 vol
$0.33 each
100,000
Filed 2020-03-03 17:46
Tx date 2020-02-27
$MMED
Mind Medicine (MindMed) Inc. (formerly Broadway Gold Mining Ltd.)
Van Damme, Paul Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options incentive stock options
00 - Opening Balance-Initial SEDI Report
Filed 2020-01-28 13:37
Tx date 2020-01-26
$QPT
Quest PharmaTech Inc.
Van Damme, Paul Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
52 - Expiration of options
$-10,000
-100,000 vol
$0.10 each
450,000
Filed 2018-09-05
Tx date 2018-09-05
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,300
+11,500 vol
$0.20 each
36,000
Filed 2018-09-01
Tx date 2018-08-31
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,500
+7,500 vol
$0.20 each
24,500
Filed 2018-08-31
Tx date 2018-08-30
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,700
+8,500 vol
$0.20 each
17,000
Filed 2018-08-30
Tx date 2018-08-29
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$500.00
+2,500 vol
$0.20 each
8,500
Filed 2018-08-29
Tx date 2018-08-28
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,200
+6,000 vol
$0.20 each
6,000
Filed 2018-04-11
Tx date 2018-01-25
$
XORTX Therapeutics Inc. (formerly, APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-11
Tx date 2018-01-25
$
XORTX Therapeutics Inc. (formerly, APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-02-02
Tx date 2018-01-25
$XRX
XORTX Therapeutics Inc. (formerly: APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-01-29
Tx date 2018-01-25
$
XORTX Therapeutics Inc. (formerly, APAC Resources Inc.)
Van Damme, Paul Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2015-11-09
Tx date 2015-11-04
$ECT
Ellipsiz Communications Ltd. (formerly NXA Inc.)
Van Damme, Paul Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-610,200 vol
67,800